Breaking News: ALS Association Urges FDA to Approve New ALS Treatment Just Approved in Canada
Amylyx Pharmaceuticals, Inc. announced that Health Products and Food Branch (HPFB) of Health Canada officially approved ALBRIOZA, known as AMX0035 in the United States, a new treatment for amyotrophic lateral sclerosis (ALS). Clinical trials showed the drug to be safe and effective for people living with ALS, a fatal neurodegenerative disease.
Committed to quality care services for the ALS community
Resources for Navigating ALS
Whether you are newly diagnosed, a military veteran, a caregiver, or someone looking to learn more about how to navigate living with ALS, we can help.
Local support in your area
We offer a variety of local support, including programs such as equipment loans and referrals to local medical professionals, provided by our chapters. We can also help you find a local treatment center or clinic, or support group.
Working tirelessly to push research forward
We expedite the discovery of treatments and a cure for ALS
- 5 genes discovered in the past 2 years
- Over 150 active research projects
- 9 global research collaborations
- New drug Radicava approved by FDA
- Several drugs in clinical trials